Tyra Biosciences Inc
(TYRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 9,931 | 6,638 | 5,508 | 4,211 | 0 |
| Operating Income | -9,931 | -6,638 | -5,508 | -4,211 | N/A |
| Other Income | 1 | -5 | -4 | 2 | 0 |
| Pre-tax Income | -9,930 | -6,643 | -5,512 | -4,209 | 0 |
| Net Income Continuous | -9,930 | -6,643 | -5,512 | -4,209 | N/A |
| Net Income | $-9,930 | $-6,643 | $-5,512 | $-4,209 | $N/A |
| EPS Basic Total Ops | 3.33 | -0.72 | -2.43 | -2.09 | N/A |
| EPS Basic Continuous Ops | 3.34 | -0.72 | -2.43 | -2.10 | N/A |
| EPS Diluted Total Ops | 3.33 | -0.72 | -2.43 | -2.09 | N/A |
| EPS Diluted Continuous Ops | 3.34 | -0.72 | -2.43 | -2.10 | N/A |
| EBITDA(a) | $-9,881 | $-6,597 | $-5,481 | $-4,189 | $N/A |